Home NDC 64896-509 BREKIYA
Product NDC 64896-509
11-digit product format 648960509
Labeler code 64896
Product ID 64896-509_1d8fa8b1-75e6-42af-863d-a775791da7a6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Dihydroergotamine Mesylate
Dosage form INJECTION
Route SUBCUTANEOUS
Labeler Amneal Pharmaceuticals LLC
Application NDA215400
Marketing category NDA
Marketing start 2025-05-16
Substance DIHYDROERGOTAMINE MESYLATE
Active strength 1 mg/mL
Pharmacologic classes Ergotamine Derivative [EPC], Ergotamines [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215400-001 BREKIYA (AUTOINJECTOR) DIHYDROERGOTAMINE MESYLATE 1MG/ML SOLUTION / SUBCUTANEOUS RLD, RS 2025-05-14
Orange Book patents# Current patent rows page 1 of 1 · 11 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215400-001 10532049 2039-02-26 Drug product 2025-05-28 N215400-001 11304942 2039-02-26 Drug product 2025-05-28 N215400-001 11819501 2039-02-26 U-4188 2025-05-28 N215400-001 11819501 2039-02-26 U-848 2025-05-28 N215400-001 12533351 2039-02-26 Drug product 2026-02-26 N215400-001 11541043 2039-03-20 Drug product 2026-05-26 N215400-001 12329749 2039-05-27 U-2718 Drug product 2026-05-26 N215400-001 12329749 2039-05-27 U-4508 Drug product 2026-05-26 N215400-001 11083712 2039-06-30 U-2718 Drug product 2026-05-26 N215400-001 11083712 2039-06-30 U-4508 Drug product 2026-05-26 N215400-001 12414941 2039-08-24 Drug product 2026-05-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215400-001 BREKIYA (AUTOINJECTOR) 1MG/ML SOLUTION / SUBCUTANEOUS RLD, RS 2025-05-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215400-001 BREKIYA (AUTOINJECTOR) 1MG/ML SOLUTION / SUBCUTANEOUS RLD, RS 2025-05-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215400-001 BREKIYA (AUTOINJECTOR) 1MG/ML SOLUTION / SUBCUTANEOUS RLD, RS 2025-05-14 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 BREKIYA (AUTOINJECTOR) 1MG/ML SOLUTION / SUBCUTANEOUS RLD, RS 2025-05-14 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N215400-001 10532049 2039-02-26 Drug product 2025-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215400-001 11304942 2039-02-26 Drug product 2025-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215400-001 11819501 2039-02-26 U-848 2025-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215400-001 11819501 2039-02-26 U-4188 2025-05-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215400-001 10532049 2039-02-26 Drug product 2025-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215400-001 11304942 2039-02-26 Drug product 2025-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215400-001 11819501 2039-02-26 U-848 2025-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215400-001 11819501 2039-02-26 U-4188 2025-05-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215400-001 10532049 2039-02-26 Drug product 2025-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215400-001 11304942 2039-02-26 Drug product 2025-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215400-001 11819501 2039-02-26 U-848 2025-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215400-001 11819501 2039-02-26 U-4188 2025-05-28 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 10532049 2039-02-26 Drug product 2025-05-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 11304942 2039-02-26 Drug product 2025-05-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 11819501 2039-02-26 U-848 2025-05-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 11819501 2039-02-26 U-4188 2025-05-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 12533351 2039-02-26 Drug product 2026-02-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 11541043 2039-03-20 Drug product 2026-05-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 12329749 2039-05-27 U-2718 Drug product 2026-05-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 12329749 2039-05-27 U-4508 Drug product 2026-05-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 11083712 2039-06-30 U-2718 Drug product 2026-05-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 11083712 2039-06-30 U-4508 Drug product 2026-05-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N215400-001 12414941 2039-08-24 Drug product 2026-05-26 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base BREKIYA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DIHYDROERGOTAMINE MESYLATE 1 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 81AXN7R2QT Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2714308 Internal RxNorm lookup 2714315 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 64896-509-01 BREKIYA 1 mL in 1 SYRINGE INJECTION 1 2 64896-509-02 BREKIYA 1 in 1 POUCH INJECTION 1 2 64896-509-02 BREKIYA 4 in 1 CARTON INJECTION 4 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 64896-509 BREKIYA (DIHYDROERGOTAMINE MESYLATE) INJECTION [AMNEAL PHARMACEUTICALS LLC] 1 Current NDC, 3 package rows 20250519_cdbf5619-767f-4165-aec2-17bdd92d9ca2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join BREKIYA DIHYDROERGOTAMINE MESYLATE Amneal Pharmaceuticals LLC cdbf5619-767f-4165-aec2-17bdd92d9ca2 2025-10-04 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 215400 application number: NDA215400 ndc (product): 64896-509
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 64896-509-01 64896050901 1 mL in 1 SYRINGE 1 ml Historical 64896-509-02 64896050902 4 POUCH in 1 CARTON (64896-509-02) / 1 SYRINGE in 1 POUCH / 1 mL in 1 SYRINGE (64896-509-01) 4 pouch 2025-05-16 No No Current